Literature DB >> 10196315

Properties of monoclonal antibodies directed against hepatitis B virus polymerase protein.

J zu Putlitz1, R E Lanford, R I Carlson, L Notvall, S M de la Monte, J R Wands.   

Abstract

Hepadnavirus polymerases are multifunctional enzymes that play critical roles during the viral life cycle but have been difficult to study due to a lack of a well-defined panel of monoclonal antibodies (MAbs). We have used recombinant human hepatitis B virus (HBV) polymerase (Pol) expressed in and purified from baculovirus-infected insect cells to generate a panel of six MAbs directed against HBV Pol protein. Such MAbs were subsequently characterized with respect to their isotypes and functions in analytical and preparative assays. Using these MAbs as probes together with various deletion mutants of Pol expressed in insect cells, we mapped the B-cell epitopes of Pol recognized by these MAbs to amino acids (aa) 8 to 20 and 20 to 30 in the terminal protein (TP) region of Pol, to aa 225 to 250 in the spacer region, and to aa 800 to 832 in the RNase H domain. Confocal microscopy and immunocytochemical studies using various Pol-specific MAbs revealed that the protein itself appears to be exclusively localized to the cytoplasm. Finally, MAbs specific for the TP domain, but not MAbs specific for the spacer or RNase H regions of Pol, appeared to inhibit Pol function in the in vitro priming assay, suggesting that antibody-mediated interference with TP may now be assessed in the context of HBV replication.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10196315      PMCID: PMC104198     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  68 in total

1.  cis-acting sequences required for encapsidation of duck hepatitis B virus pregenomic RNA.

Authors:  R C Hirsch; D D Loeb; J R Pollack; D Ganem
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

2.  Mutations affecting hepadnavirus plus-strand DNA synthesis dissociate primer cleavage from translocation and reveal the origin of linear viral DNA.

Authors:  S Staprans; D D Loeb; D Ganem
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

3.  Identification of a signal necessary for initiation of reverse transcription of the hepadnavirus genome.

Authors:  C Seeger; J Maragos
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

4.  Human recombinant antibody fragments neutralizing human immunodeficiency virus type 1 reverse transcriptase provide an experimental basis for the structural classification of the DNA polymerase family.

Authors:  N Gargano; S Biocca; A Bradbury; A Cattaneo
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

5.  Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine.

Authors:  R Ling; D Mutimer; M Ahmed; E H Boxall; E Elias; G M Dusheiko; T J Harrison
Journal:  Hepatology       Date:  1996-09       Impact factor: 17.425

6.  Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo.

Authors:  G A Tipples; M M Ma; K P Fischer; V G Bain; N M Kneteman; D L Tyrrell
Journal:  Hepatology       Date:  1996-09       Impact factor: 17.425

7.  Replication of DHBV genomes with mutations at the sites of initiation of minus- and plus-strand DNA synthesis.

Authors:  L D Condreay; T T Wu; C E Aldrich; M A Delaney; J Summers; C Seeger; W S Mason
Journal:  Virology       Date:  1992-05       Impact factor: 3.616

8.  The expression of hepatitis B virus polymerase in hepatocytes during chronic HBV infection.

Authors:  M J McGarvey; R D Goldin; P Karayiannis; H C Thomas
Journal:  J Viral Hepat       Date:  1996-03       Impact factor: 3.728

9.  Hepadnaviral assembly is initiated by polymerase binding to the encapsidation signal in the viral RNA genome.

Authors:  R Bartenschlager; H Schaller
Journal:  EMBO J       Date:  1992-09       Impact factor: 11.598

10.  Sequence-independent RNA cleavages generate the primers for plus strand DNA synthesis in hepatitis B viruses: implications for other reverse transcribing elements.

Authors:  D D Loeb; R C Hirsch; D Ganem
Journal:  EMBO J       Date:  1991-11       Impact factor: 11.598

View more
  14 in total

1.  The majority of duck hepatitis B virus reverse transcriptase in cells is nonencapsidated and is bound to a cytoplasmic structure.

Authors:  E Yao; Y Gong; N Chen; J E Tavis
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Expression of RNase H of human hepatitis B virus polymerase in Escherichia coli.

Authors:  Hong Cheng; Hui-Zhong Zhang; Wan-An Shen; Yan-Fang Liu; Fu-Cheng Ma
Journal:  World J Gastroenterol       Date:  2003-03       Impact factor: 5.742

3.  Unusual naturally occurring humoral and cellular mutated epitopes of hepatitis B virus in a chronically infected argentine patient with anti-HBs antibodies.

Authors:  María L Cuestas; Verónica L Mathet; Vanesa Ruiz; María L Minassian; Cintia Rivero; Andrea Sala; Daniel Corach; Analía Alessio; Marcia Pozzati; Bernardo Frider; José R Oubiña
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

4.  Human hepatitis B virus polymerase interacts with the molecular chaperonin Hsp60.

Authors:  S G Park; G Jung
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

5.  Hepatitis B Virus Polymerase Localizes to the Mitochondria, and Its Terminal Protein Domain Contains the Mitochondrial Targeting Signal.

Authors:  Nuruddin Unchwaniwala; Nathan M Sherer; Daniel D Loeb
Journal:  J Virol       Date:  2016-09-12       Impact factor: 5.103

Review 6.  Spacer Domain in Hepatitis B Virus Polymerase: Plugging a Hole or Performing a Role?

Authors:  Caitlin Pley; José Lourenço; Anna L McNaughton; Philippa C Matthews
Journal:  J Virol       Date:  2022-04-12       Impact factor: 6.549

7.  Antibodies to the core proteins of Nairobi sheep disease virus/Ganjam virus reveal details of the distribution of the proteins in infected cells and tissues.

Authors:  Lidia Lasecka; Abdelghani Bin-Tarif; Anne Bridgen; Nicholas Juleff; Ryan A Waters; Michael D Baron
Journal:  PLoS One       Date:  2015-04-23       Impact factor: 3.240

Review 8.  Molecular, Evolutionary, and Structural Analysis of the Terminal Protein Domain of Hepatitis B Virus Polymerase, a Potential Drug Target.

Authors:  Timothy S Buhlig; Anastasia F Bowersox; Daniel L Braun; Desiree N Owsley; Kortney D James; Alfredo J Aranda; Connor D Kendrick; Nicole A Skalka; Daniel N Clark
Journal:  Viruses       Date:  2020-05-22       Impact factor: 5.048

9.  The hepatitis B virus ribonuclease H is sensitive to inhibitors of the human immunodeficiency virus ribonuclease H and integrase enzymes.

Authors:  John E Tavis; Xiaohong Cheng; Yuan Hu; Michael Totten; Feng Cao; Eleftherios Michailidis; Rajeev Aurora; Marvin J Meyers; E Jon Jacobsen; Michael A Parniak; Stefan G Sarafianos
Journal:  PLoS Pathog       Date:  2013-01-22       Impact factor: 6.823

10.  Naturally occurring hepatitis B virus B-cell and T-cell epitope mutants in hepatitis B vaccinated children.

Authors:  Yu-Min Lin; Guey-Mei Jow; Shu-Chi Mu; Bing-Fang Chen
Journal:  ScientificWorldJournal       Date:  2013-11-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.